| Tapestry Pharmaceuticals, Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120077871 | 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof - Provided herein are compounds, compositions containing the compounds, and methods for the treatment of cancer in a cancer patient. In particular, the compounds are made by a process comprising treating a first compound represented by either Formula G′ or Formula M′: | 03-29-2012 |
| 20110135712 | Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration - The present invention relates to a novel chemical compound of formula S-(1): | 06-09-2011 |
| 20110028539 | Biologically active taxane analogs and methods of treatment - The present application relates to new taxane analogs, pharmaceutical compositions comprising such analogs and methods of treating cancer comprising such compositions. The compounds according to the present application have the general formula: | 02-03-2011 |
| 20110009480 | Biologically active taxane analogs and methods of treatment - The present application relates to new taxane analogs, pharmaceutical compositions comprising such analogs and methods of treating cancer comprising such compositions. The compounds according to the present application have the general formula: | 01-13-2011 |
| 20100324128 | 9, 10-Alpha, Alpha-OH-Taxane Analogs and Methods for Production Thereof - The present invention relates to a method for the treatment of cancer in a cancer patient. In particular, the invention provides a method for the treatment comprising administering a taxane compound to a cancer patient, wherein the taxane compound is made by a process comprising treating a first compound represented by either Formula G′ or Formula M′: | 12-23-2010 |
| 20080269319 | Biologically active taxane analogs and methods of treatment - The present application relates to new taxane analogs, pharmaceutical compositions comprising such analogs and methods of treating cancer comprising such compositions. The compounds according to the present application have the general formula: | 10-30-2008 |
